BDF
CELG

Balasa Dinverno & Foltz’s Celgene Corp CELG Stock Holding History

Balasa Dinverno & Foltz’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,445
Closed -$243K – 283
2019
Q3 		$243K Hold
2,445
– – 0.03% 218
2019
Q2 		$226K Sell
2,445
-57
-2% -$5.41K 0.03% 224
2019
Q1 		$236K Buy
+2,502
New +$219K 0.03% 217
2018
Q4 		– Sell
-3,714
Closed -$332K – 258
2018
Q3 		$332K Buy
3,714
+81
+2% +$7.16K 0.04% 181
2018
Q2 		$289K Buy
3,633
+241
+7% +$20K 0.04% 178
2018
Q1 		$303K Sell
3,392
-572
-14% -$54.9K 0.05% 165
2017
Q4 		$414K Sell
3,964
-165
-4% -$18.6K 0.06% 135
2017
Q3 		$602K Buy
4,129
+40
+1% +$5.45K 0.09% 98
2017
Q2 		$531K Buy
4,089
+91
+2% +$11.2K 0.09% 111
2017
Q1 		$497K Sell
3,998
-258
-6% -$30.9K 0.08% 103
2016
Q4 		$493K Buy
4,256
+494
+13% +$55K 0.08% 95
2016
Q3 		$393K Sell
3,762
-162
-4% -$17.5K 0.07% 115
2016
Q2 		$387K Sell
3,924
-220
-5% -$22.8K 0.07% 113
2016
Q1 		$415K Sell
4,144
-215
-5% -$22.1K 0.07% 103
2015
Q4 		$522K Sell
4,359
-439
-9% -$50.8K 0.09% 92
2015
Q3 		$519K Buy
4,798
+36
+0.8% +$4.47K 0.09% 87
2015
Q2 		$551K Buy
4,762
+75
+2% +$8.57K 0.09% 79
2015
Q1 		$540K Sell
4,687
-613
-12% -$73.3K 0.08% 78
2014
Q4 		$593K Sell
5,300
-20
-0.4% -$2.11K 0.09% 78
2014
Q3 		$504K Buy
5,320
+20
+0.4% +$1.8K 0.08% 84
2014
Q2 		$455K Buy
5,300
+1,140
+27% +$86.7K 0.05% 89
2014
Q1 		$290K Buy
4,160
+438
+12% +$34.7K 0.04% 124
2013
Q4 		$314K Buy
3,722
+20
+0.5% +$1.58K 0.04% 105
2013
Q3 		$285K Buy
3,702
+82
+2% +$5.75K 0.05% 103
2013
Q2 		$212K Buy
+3,620
New +$218K 0.04% 124

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Balasa Dinverno & Foltz's CELG Position: Q4 2019 in Review

Balasa Dinverno & Foltz sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,445 shares — an estimated $243K sold.

Balasa Dinverno & Foltz first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $602K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Balasa Dinverno & Foltz reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 2,445 Celgene Corp shares in Q4 2019, an estimated $243K.
  • Balasa Dinverno & Foltz first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Balasa Dinverno & Foltz's Celgene Corp position peaked at $602K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Balasa Dinverno & Foltz's 13F filing for Q4 2019, filed 22 Jan 2020.